![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1420265
¼¼°èÀÇ º´¿ø¿ë ¸ê±Õ ÀåÄ¡ ¼ºÀå ±âȸGlobal Hospital Sterilization Device Growth Opportunities |
Çõ½ÅÀû ¼ºÀåÀ» º¸ÀåÇÏ´Â ¼Ò¸ðǰ ¹× ¼ºñ½º
¼±Áø±¹¿¡¼´Â ¸ê±Õ ÀÚº» ¼³ºñÀÇ ¼ºÀåÀÌ Æ÷È »óÅ¿¡ À̸£·¶±â ¶§¹®¿¡ ¼Ò¸ðǰ°ú ¼ºñ½º°¡ ¸ê±Õ ÀåÄ¡¿¡ ´ëÇÑ Àü ¼¼°è ¼ö¿ä¸¦ ÁÖµµÇÒ °ÍÀÔ´Ï´Ù. °³¹ßµµ»ó±¹¿¡¼´Â ÀÇ·á ½Ã¼³ÀÇ ¼ö°¡ Áõ°¡ÇÏ°í °¨¿°À» ÁÙÀÌ´Â µ¥ ÃÊÁ¡À» ¸ÂÃß¸é¼ ¸ê±Õ ÀÚº» ¼³ºñ¿Í ¼Ò¸ðǰ ¹× ¼ºñ½ºÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÒ °ÍÀÔ´Ï´Ù.
¼¼°èÀÇ ¸ê±Õ ÀåÄ¡ ½ÃÀåÀº ¼¼Ã´±â(¿À¿° Á¦°Å ÀåÄ¡), ÀÚµ¿ ³»½Ã°æ Àç󸮱â(AER), Áõ±â ¸ê±Õ ÀåÄ¡, Àú¿Â ÀåÄ¡(EtO ÀåÄ¡, Àú¿Â Áõ±â Æ÷¸§¾Ëµ¥È÷µå, H2O2), ¼Ò¸ðǰ ¹× ¼ºñ½º·Î ¼¼ºÐȵ˴ϴÙ. Áö¸®Àû ¹üÀ§´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾Æ ÅÂÆò¾ç, ³²¹Ì, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¸¦ Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ ¿¬±¸´Â °¡Ä¡(´Þ·¯) ¹× Æò±Õ °¡°Ý(¸ê±Õ ÀÚº» ¼³ºñÀÇ °æ¿ì ´Þ·¯), °æÀï ȯ°æ, ½ÃÀå µ¿ÀÎ ¹× Á¦¾à, µ¿Çâ ¹× ¼ºÀå ±âȸ Ãø¸é¿¡¼ ½ÃÀå ±Ô¸ð¸¦ ´Ù·ì´Ï´Ù.
Á¶»ç ¹üÀ§´Â º´¿ø¿ë ¸ê±Õ ÀåÄ¡(Hospital Sterilization Device) ¹× ¼ºñ½º·Î Á¦Çѵ˴ϴÙ. º´¿ø ³» °¨¿°(HAI)À» ÁÙÀÌ´Â µ¥ ÃÊÁ¡À» ¸ÂÃß¸é¼ ºñ¿ëÀ» Àý°¨Çϱâ À§ÇØ ´õ °·ÂÇÑ ¸ê±Õ ¹æ¹ýÀÌ µîÀåÇß½À´Ï´Ù. ¹Ì±¹ Áúº´ÅëÁ¦¿¹¹æ¼¾ÅÍ¿¡ µû¸£¸é HAI´Â ¸Å³â ¾à 284¾ï ´Þ·¯ÀÇ Á÷Á¢ ºñ¿ë°ú »ç¸Á ¹× »ý»ê¼º ¼Õ½Ç°ú °°Àº 124¾ï ´Þ·¯ÀÇ °£Á¢ »çȸÀû ºñ¿ëÀ» ÃÊ·¡ÇÕ´Ï´Ù. CSSDÀÇ ÀÚµ¿È´Â ÀÇ·á ½Ã¼³¿¡ »ó´çÇÑ ºñ¿ë È¿À²¼º, ¿öÅ©Ç÷Π°³¼±, ¸®¼Ò½º ÃÖÀûȸ¦ °¡Á®¿Ã °ÍÀÔ´Ï´Ù. ¼±Áø±¹¿¡¼´Â ÀÚµ¿È°¡ Ç¥ÁØÀÌ µÇ°í ÀÖÀ¸¸ç, °³¹ßµµ»ó±¹¿¡¼´Â ´õ Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. CSSD ÀÚµ¿È¿Í ¸ê±Õ¿¡ µðÁöÅÐ ±â¼úÀ» »ç¿ëÇÏ¸é ¼öÀÍÀÌ Áõ°¡ÇÒ °ÍÀÔ´Ï´Ù. ¹Ì±¹°ú À¯·´ÀÇ °·ÂÇÑ ±ÔÁ¦ ȯ°æ°ú Áö¼Ó °¡´É¼º ¸ñÇ¥´Â ¼øÈ¯ °æÁ¦, Ã¥ÀÓ°¨ ÀÖ´Â ¼Òºñ, ÀÇ·á ±â±â Àç»ç¿ë¿¡ ÃÊÁ¡À» ¸ÂÃâ °ÍÀÔ´Ï´Ù.
"Consumables and Services to Ensure Transformational Growth."
Consumables and services will lead the global demand for sterilization devices because sterilization capital equipment growth is becoming saturated in developed economies. In developing economies, the growing number of healthcare facilities and the focus on reducing infections will boost the uptake of sterilization capital equipment, and consumables and services.
The global sterilization devices market is segmented into washer units (decontamination units), automatic endoscopic reprocessors (AERs), steam sterilization units, low-temperature units (EtO units, low-temperature steam formaldehyde, H2O2), and consumables and services. The geographic scope covers North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. This study covers market sizing in terms of value ($) and average prices ($ for sterilization capital equipment), competitive landscape, market drivers and restraints, trends, and growth opportunities.
The study scope is limited to sterilization devices and services within healthcare facilities. The focus on reducing hospital-acquired infections (HAIs) has ushered stronger sterilization methods to curtail costs. According to the US CDC, HAIs result in about $28.4 billion in direct costs and $12.4 billion in indirect social costs, such as deaths and loss of productivity, every year. Automation of the central sterile services department (CSSD) will bring about significant cost efficiencies, improved workflow, and optimization of resources for healthcare facilities. Automation is becoming a standard in developed economies, and developing economies offer greater growth opportunities. CSSD automation and the use of digital technologies in sterilization will boost revenue. The strong regulatory environment in the United States and Europe and sustainability goals will turn the focus on circular economy, responsible consumption, and re-use of medical devices.